ats
Boehringer widens IPF drug’s reach
May 18, 2015Sales and Marketing Boehringer, Esbriet, ats, brett wells, nintedanib, ofev
Boehringer Ingelheim has highlighted new data for its idiopathic pulmonary fibrosis (IPF) treatment Ofev in a Phase II study on …
IPF grabs headlines at American Thoracic Society conference
July 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IPF, ats, ats 2014, brett wells, idiopathic pulmonary fibrosis, san diego, thoracic society
Just prior to landing in San Diego it was somewhat disconcerting to see fire spreading across the terrain and huge …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
